RecruitingNot Applicable

Phenotypic Manifestations of Hereditary ATTR Amyloidosis

Argentina57 participantsStarted 2024-09-01

Plain-language summary

This study focuses on hereditary transthyretin amyloidosis (ATTRv) with the Val50Met variant in a non endemic aerea

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All subjects between 20 and 70 years of age, carriers of the Val50Met variant Exclusion Criteria: * Patients who refuse to participate.

What they're measuring

Describe the phenotypic variables (preclinical, cardiological, neurological and mixed) in patients carrying the TTR Val50Met variant in a non-endemic population.

Timeframe: 2 years

Trial details

NCT IDNCT07124377

SponsorHospital 9 de Julio de Las Breñas

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2026-12-30

Contact for this trial

Mauricio MT TOMEI, MD

+5493731558832 mht10@hotmail.com

View on ClinicalTrials.gov More Hereditary Amyloidosis, Transthyretin-Related trials